Tag:
Newron Pharmaceuticals
Latest Headlines
Latest Headlines
Newron soars on positive PhIII results, $26M pact for Parkinson's drug
Despite being left at the M&A altar last fall after a key partnership deal collapsed, Newron says it has successfully completed two late-stage studies of its experimental Parkinson's drug.
Biotie backs out of $63M Newron Pharma buyout
Newron Pharmaceuticals has been left at the altar. Finland's Biotie has decided to nix plans to acquire Newron after Merck Serono decided to give up rights to Newron's Parkinson's drug and lead
